| Novel mutations target distinct subgroups of medulloblastoma G Robinson, M Parker, TA Kranenburg, C Lu, X Chen, L Ding, TN Phoenix, ... Nature 488 (7409), 43-48, 2012 | 916 | 2012 |
| The timing of cortical neurogenesis is encoded within lineages of individual progenitor cells Q Shen, Y Wang, JT Dimos, CA Fasano, TN Phoenix, IR Lemischka, ... Nature neuroscience 9 (6), 743-751, 2006 | 672 | 2006 |
| C11orf95–RELA fusions drive oncogenic NF-κB signalling in ependymoma M Parker, KM Mohankumar, C Punchihewa, R Weinlich, JD Dalton, Y Li, ... Nature 506 (7489), 451-455, 2014 | 661 | 2014 |
| Resolving medulloblastoma cellular architecture by single-cell genomics V Hovestadt, KS Smith, L Bihannic, MG Filbin, MKL Shaw, A Baumgartner, ... Nature 572 (7767), 74-79, 2019 | 327 | 2019 |
| Medulloblastoma genotype dictates blood brain barrier phenotype TN Phoenix, DM Patmore, S Boop, N Boulos, MO Jacus, YT Patel, ... Cancer cell 29 (4), 508-522, 2016 | 294 | 2016 |
| Bmi-1 cooperates with Foxg1 to maintain neural stem cell self-renewal in the forebrain CA Fasano, TN Phoenix, E Kokovay, N Lowry, Y Elkabetz, JT Dimos, ... Genes & development 23 (5), 561-574, 2009 | 204 | 2009 |
| A single-cell transcriptional atlas of the developing murine cerebellum RA Carter, L Bihannic, C Rosencrance, JL Hadley, Y Tong, TN Phoenix, ... Current Biology 28 (18), 2910-2920. e2, 2018 | 176 | 2018 |
| An integrated in vitro and in vivo high-throughput screen identifies treatment leads for ependymoma JM Atkinson, AA Shelat, AM Carcaboso, TA Kranenburg, LA Arnold, ... Cancer cell 20 (3), 384-399, 2011 | 125 | 2011 |
| Spred1, a negative regulator of Ras–MAPK–ERK, is enriched in CNS germinal zones, dampens NSC proliferation, and maintains ventricular zone structure TN Phoenix, S Temple Genes & development 24 (1), 45-56, 2010 | 94 | 2010 |
| Engineered Wnt ligands enable blood-brain barrier repair in neurological disorders M Martin, S Vermeiren, N Bostaille, M Eubelen, D Spitzer, M Vermeersch, ... Science 375 (6582), eabm4459, 2022 | 81 | 2022 |
| Molecular characterisation of transport mechanisms at the developing mouse blood–CSF interface: a transcriptome approach SA Liddelow, S Temple, K Møllgård, R Gehwolf, A Wagner, H Bauer, ... PloS one 7 (3), e33554, 2012 | 70 | 2012 |
| Persistent expression of VCAM1 in radial glial cells is required for the embryonic origin of postnatal neural stem cells XL Hu, G Chen, S Zhang, J Zheng, J Wu, QR Bai, Y Wang, J Li, H Wang, ... Neuron 95 (2), 309-325. e6, 2017 | 61 | 2017 |
| Orthotopic models of pediatric brain tumors in zebrafish CJ Eden, B Ju, M Murugesan, TN Phoenix, B Nimmervoll, Y Tong, ... Oncogene 34 (13), 1736-1742, 2015 | 59 | 2015 |
| Everolimus improves the efficacy of dasatinib in PDGFRα-driven glioma Z Miklja, VN Yadav, RT Cartaxo, R Siada, CC Thomas, JR Cummings, ... The Journal of clinical investigation 130 (10), 5313-5325, 2020 | 57 | 2020 |
| Novel MYC-driven medulloblastoma models from multiple embryonic cerebellar cells D Kawauchi, RJ Ogg, L Liu, DJH Shih, D Finkelstein, BL Murphy, JE Rehg, ... Oncogene 36 (37), 5231-5242, 2017 | 54 | 2017 |
| Combined therapy of AXL and HDAC inhibition reverses mesenchymal transition in diffuse intrinsic pontine glioma MH Meel, MC de Gooijer, DS Metselaar, ACP Sewing, K Zwaan, ... Clinical Cancer Research 26 (13), 3319-3332, 2020 | 53 | 2020 |
| Generation of diffuse intrinsic pontine glioma mouse models by brainstem-targeted in utero electroporation SK Patel, RM Hartley, X Wei, R Furnish, F Escobar-Riquelme, H Bear, ... Neuro-oncology 22 (3), 381-392, 2020 | 51 | 2020 |
| Glioblastoma genetic drivers dictate the function of tumor-associated macrophages/microglia and responses to CSF1R inhibition R Rao, R Han, S Ogurek, C Xue, LM Wu, L Zhang, L Zhang, J Hu, ... Neuro-oncology 24 (4), 584-597, 2022 | 36 | 2022 |
| PPM1D mutations are oncogenic drivers of de novo diffuse midline glioma formation P Khadka, ZJ Reitman, S Lu, G Buchan, G Gionet, F Dubois, DM Carvalho, ... Nature communications 13 (1), 604, 2022 | 26 | 2022 |
| MEK/MELK inhibition and blood–brain barrier deficiencies in atypical teratoid/rhabdoid tumors MH Meel, M Guillén Navarro, MC De Gooijer, DS Metselaar, P Waranecki, ... Neuro-oncology 22 (1), 58-69, 2020 | 25 | 2020 |
